Clinicopathological features and androgen receptor expression in triple negative breast cancer at Lagos, Nigeria

INTRODUCTION: Androgen receptor (AR) is one of the predominant nuclear hormone receptors in invasive breast cancer and can be explored as a biomarker of response for targeted anti-androgen therapy, especially in the setting of triple negative breast cancer (TNBC). Luminal AR is a distinct subtype am...

Descripción completa

Detalles Bibliográficos
Autores principales: Haruna, Muibat, Daramola, Adetola Olubunmi, Awolola, Nicholas Awodele, Badr, Nahla Mustafa, Banjo, Adekunbiola Aina Fehintola, Shaaban, Abeer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666286/
https://www.ncbi.nlm.nih.gov/pubmed/36405944
http://dx.doi.org/10.3332/ecancer.2022.1452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666286/
https://www.ncbi.nlm.nih.gov/pubmed/36405944
http://dx.doi.org/10.3332/ecancer.2022.1452

Ejemplares similares